NOX1 and dentin dysplasia: Although our data support that NOX1-deficiency is sufficient to prevent endothelial activation and myocardial remodelling in a mouse model of metabolic heart disease and find NOX1 upregulated in peripheral monocytes of humans with DD due to other cause, it has to be pointed out that until now, no NOX1-targeting therapy is available for human use.